ES2920394T3 - Solución de isoxazolina que contiene vitamina E para usar con agua potable desinfectada - Google Patents

Solución de isoxazolina que contiene vitamina E para usar con agua potable desinfectada Download PDF

Info

Publication number
ES2920394T3
ES2920394T3 ES16733385T ES16733385T ES2920394T3 ES 2920394 T3 ES2920394 T3 ES 2920394T3 ES 16733385 T ES16733385 T ES 16733385T ES 16733385 T ES16733385 T ES 16733385T ES 2920394 T3 ES2920394 T3 ES 2920394T3
Authority
ES
Spain
Prior art keywords
drinking water
pharmaceutical composition
isoxazoline
water
medicated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16733385T
Other languages
English (en)
Spanish (es)
Inventor
Annie Flochlay-Sigognault
Anne Lehay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Application granted granted Critical
Publication of ES2920394T3 publication Critical patent/ES2920394T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Fodder In General (AREA)
  • Mechanical Engineering (AREA)
  • Ceramic Engineering (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
ES16733385T 2015-06-23 2016-06-22 Solución de isoxazolina que contiene vitamina E para usar con agua potable desinfectada Active ES2920394T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15173454 2015-06-23
PCT/EP2016/064449 WO2016207234A1 (en) 2015-06-23 2016-06-22 Isoxazoline solution containing vitamin e for use with sanitized drinking water

Publications (1)

Publication Number Publication Date
ES2920394T3 true ES2920394T3 (es) 2022-08-03

Family

ID=53488226

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16733385T Active ES2920394T3 (es) 2015-06-23 2016-06-22 Solución de isoxazolina que contiene vitamina E para usar con agua potable desinfectada

Country Status (10)

Country Link
US (3) US20180169073A1 (cg-RX-API-DMAC7.html)
EP (1) EP3313400B1 (cg-RX-API-DMAC7.html)
JP (1) JP6933983B2 (cg-RX-API-DMAC7.html)
CN (1) CN107750159B (cg-RX-API-DMAC7.html)
BR (1) BR112017027855B1 (cg-RX-API-DMAC7.html)
ES (1) ES2920394T3 (cg-RX-API-DMAC7.html)
HU (1) HUE059228T2 (cg-RX-API-DMAC7.html)
MX (1) MX383746B (cg-RX-API-DMAC7.html)
PL (1) PL3313400T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016207234A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170232024A1 (en) 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
KR102668200B1 (ko) * 2015-10-28 2024-05-23 주식회사유한양행 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
CN111655241B (zh) 2017-12-15 2024-10-15 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
MX2022007455A (es) 2019-12-18 2022-08-15 Elanco Tiergesundheit Ag Derivados de isoxazolina como plaguicidas.
EP4185585A1 (en) 2020-07-24 2023-05-31 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
CN114306231B (zh) * 2021-12-29 2023-03-24 天津市中升挑战生物科技有限公司 一种氟雷拉纳杀虫剂及其制备方法和应用
CN115266988A (zh) * 2022-08-01 2022-11-01 江苏慧聚药业股份有限公司 一种氟雷拉钠有关物质的检测方法
CN117064851A (zh) * 2023-09-20 2023-11-17 中国农业大学 一种异噁唑啉类驱虫药制剂的制备方法
CN118477040B (zh) * 2024-04-11 2025-02-25 河北威远药业有限公司 一种氟雷拉纳溶液的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
IL153120A0 (en) 2000-06-27 2003-06-24 Procter & Gamble Water treatment compositions
US20050005868A1 (en) * 2003-07-11 2005-01-13 Shepard Allan T. Animal drinking water production
CN102558082B (zh) 2004-03-05 2015-09-30 日产化学工业株式会社 异噁唑啉取代苯甲酰胺化合物的制备中间体
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
JP2007319124A (ja) * 2006-06-02 2007-12-13 Nippon Tablet Kk 健康食品
AU2008235089B8 (en) 2007-04-10 2014-04-10 Bayer Intellectual Property Gmbh Insecticidal aryl isoxazoline derivatives
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
CA2971008A1 (en) 2007-06-27 2008-12-31 E. I. Du Pont De Nemours And Company Animal pest control method
US20090024541A1 (en) * 2007-07-20 2009-01-22 Gary Kremen Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
CN102088856B (zh) * 2008-07-09 2015-11-25 巴斯夫欧洲公司 包含异*唑啉化合物的杀虫活性混合物i
US7951404B2 (en) 2008-07-11 2011-05-31 Sanosil Ag Concentrate for preparing a disinfectant and methods for its preparation and use
CA2747060A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
AR074790A1 (es) 2008-12-19 2011-02-09 Novartis Ag Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente.
PL3560923T3 (pl) 2009-12-17 2021-12-27 Boehringer Ingelheim Animal Health USA Inc. Dihydroazolowe kompozycje przeciwpasożytnicze i kompozycje je zawierające
WO2011092287A1 (en) 2010-02-01 2011-08-04 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
WO2011124998A1 (en) 2010-04-08 2011-10-13 Pfizer Inc. Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
WO2012155352A1 (en) 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
WO2013026695A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
WO2013026931A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
SG11201400558YA (en) * 2011-09-12 2014-04-28 Merial Ltd Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
CA2924537C (en) 2013-09-30 2018-01-16 Todd P. Foster Long-acting spiro-isoxazoline formulations
US9371293B2 (en) 2013-10-25 2016-06-21 Sumitomo Chemical Company, Limited Isoxazoline compound composition
ES2905848T3 (es) 2013-11-01 2022-04-12 Boehringer Ingelheim Animal Health Usa Inc Compuestos de isoxazolina antiparasitarios y plaguicidas
EP3079474B1 (en) * 2013-12-10 2019-07-03 Intervet International B.V. Antiparasitic use of isoxazoline compounds
CN110327468B (zh) * 2013-12-20 2023-04-28 英特维特国际股份有限公司 异噁唑啉组合物及其在预防或治疗动物的寄生虫侵袭中的用途
US10272071B2 (en) * 2013-12-20 2019-04-30 Intervet Inc. Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
MX2017005721A (es) * 2014-11-03 2017-07-28 Zoetis Services Llc Composicion veterinaria masticable agradable al paladar.

Also Published As

Publication number Publication date
BR112017027855B1 (pt) 2022-11-16
BR112017027855A2 (cg-RX-API-DMAC7.html) 2018-08-21
US20180169073A1 (en) 2018-06-21
US11179372B2 (en) 2021-11-23
JP6933983B2 (ja) 2021-09-08
EP3313400B1 (en) 2022-06-15
CN107750159A (zh) 2018-03-02
PL3313400T3 (pl) 2022-07-25
JP2018521995A (ja) 2018-08-09
MX2017016671A (es) 2018-03-15
WO2016207234A1 (en) 2016-12-29
MX383746B (es) 2025-03-14
EP3313400A1 (en) 2018-05-02
US20210354283A1 (en) 2021-11-18
US20190343808A1 (en) 2019-11-14
CN107750159B (zh) 2021-10-29
HUE059228T2 (hu) 2022-10-28
US11878006B2 (en) 2024-01-23

Similar Documents

Publication Publication Date Title
ES2920394T3 (es) Solución de isoxazolina que contiene vitamina E para usar con agua potable desinfectada
ES3036365T3 (en) Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
ES2261229T3 (es) Uso de spinosad o de una formulacion que comprende spinosad.
ES2836108T3 (es) Derivados de 1-N-arilpirazol para interrumpir la transmisión de enfermedades transmitidas por mosquitos
ES2950885T3 (es) Uso de compuestos de isoxazolina en aves de corral
BRPI0823302B1 (pt) composição farmacêutica líquida que contém um derivado de n-fenilpirazol, e utilização para a preparação de um medicamento veterinário tópico para lutar contra pulgas
PT101274B (pt) Derivados de 1-{n-alquil-n-(halo-3'-piridilmetil)amino}-1-mono/dialquilamino-2-nitroetileno para utilizacao como ingredientes activos num metodo para o controlo de pulgas em animais domesticos
ES2903474T3 (es) Juego de piezas que comprende una combinación de dinotefurano/permetrina/piriproxifeno para uso tópico y oxima de milbemicina oral para controlar la propagación de la dirofilariosis
KR101544049B1 (ko) 넙치 양식 어류 스쿠치카병 방제용 및 치료용 조성물
JP2014517066A (ja) 大環状ラクトンおよびレバミゾールを含む抗寄生生物性組成物、ならびに寄生生物感染の処置方法
EP3331365B1 (en) Agent for fighting fish parasites
DK180300B1 (en) Use of milbemycinoxime against sea lice in fish
AU2016200283B2 (en) LEVIA: A New Injectable Parasiticidal Veterinary Formulation of Levamisole HCI and Ivermectin Solution
RU2791637C2 (ru) Изоксазолиновые композиции и их применение в профилактике или лечении паразитарных инвазий животных
Made Chemical Names
BR112015013491B1 (pt) Composição veterinária ectoparasítica injetável e uso da mesma
UA116365U (uk) Препарат ветеринарний "бровермектин водорозчинний"